Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma-Reference-Cited by-同舟云学术

Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma

Published:2023-01 Issue: Volume:27 Page:101568
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Hao Bo,Zhang Ziyao,Lu Zilong^ORCID,Xiong Juan,Fan Tao,Song Congkuan,He Ruyuan,Zhang Lin,Pan Shize,Li Donghang,Meng Heng,Lin Weichen,Luo Bin,Yang Jinfeng,Li Ning,Geng Qing^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. FGFR1 amplification in squamous cell carcinoma of the lung;Heist;J. Thorac. Oncol.,2012

3. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets;Wood;Cancer Treat. Rev.,2014

4. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy;Pitt;Ann. Oncol.,2016

5. Unravelling biology and shifting paradigms in cancer with single-cell sequencing;Baslan;Nat. Rev. Cancer,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer;International Immunopharmacology;2024-08

2. Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy;Frontiers in Immunology;2024-07-16

3. Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor–associated myocarditis;Cardiovascular Research;2024-06-08

4. TIGIT Regulates T Cell Inflammation in Airway Inflammatory Diseases;Inflammation;2024-05-23

5. A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer;Clinical Cancer Research;2024-04-29